[ad_1] Pfizer, Amgen and Bristol-Myers Squibb bought makers of proven drugs ahead of potential rising competition from generics. [ad_2] Source link
Tag: Acquisitions/Mergers
EU Foreign-Subsidy Limits Target China, but Also Hit U.S. Companies
[ad_1] Under rules taking effect next year, the Inflation Reduction Act and other aid could trigger hefty reporting requirements, competition lawyers say. [ad_2] Source link
Healthcare Deal-Making Set to Surge in 2023
[ad_1] Activity has picked up in recent months, and signs point to a strong year ahead. [ad_2] Source link
Microsoft Responds to FTC Suit Over Activision Deal
[ad_1] The software giant filed court documents opposing claims that the $75 billion transaction would harm competition in the videogame industry. [ad_2] Source link
WSJ News Exclusive | Hundreds of Tyson Foods Employees Expected to Depart as Company Closes Offices
[ad_1] WSJ News Exclusive Business The company has said its planned office closures are part of an effort to consolidate its corporate employees in Arkansas [ad_2] Source link
Opinion | ESG Won’t Stop the FTC
[ad_1] Companies can get creative when they want to fend off a government challenge to an illegal merger. As chair of the Federal Trade Commission, I’ve heard would-be merging parties…